Is biogen.de Safe? Security Analysis for Biogen
https://biogen.deCheck if biogen.de is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for biogen.de
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Biogen Deutschland operates as a leading biotechnology company specializing in the research, development, and provision of innovative pharmaceutical therapies targeting complex and severe diseases, particularly in neurology and rare disorders. The website reflects a mature enterprise-level digital presence with comprehensive content tailored to patients, healthcare professionals, and partners. The company maintains a strong market position with a clear focus on innovation and patient care. Technically, the site leverages Adobe Experience Manager CMS, integrates modern analytics and consent management tools, and is hosted on AWS infrastructure, indicating a robust and scalable platform. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though there is room for improvement in explicit security policy disclosures and security headers. Overall, the site demonstrates high professionalism, compliance with GDPR, and trustworthy branding.
Detected Technologies
6 urgent findings need attention
1 critical · 5 high
Keep biogen.de under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
1 finding
95/100
GDPR Compliance
2 findings
83/100
NIS2 Compliance
8 findings
17/100
Email Security
5 findings
60/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Biogen's market positioning as a global biotechnology leader is supported by a diverse portfolio of therapies addressing neurological and immunological conditions. The business model centers on pharmaceutical innovation and patient-centric services, targeting healthcare providers and patients. The website's multilingual and regional domain structure indicates a broad international footprint. The absence of direct contact emails or phone numbers suggests a controlled communication channel via contact forms, aligning with corporate compliance standards. The company’s digital ecosystem includes social media engagement and comprehensive cookie management, reflecting a mature marketing and compliance strategy.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a good security baseline with HTTPS, HttpOnly cookies, and a robust cookie consent framework via Cookiebot. However, the lack of visible security headers such as Content-Security-Policy and absence of published security policies or incident response contacts represent areas for enhancement. No vulnerabilities or exposed sensitive data were detected in the content. The site does not provide a vulnerability disclosure program or security.txt file, which could improve transparency and trust. Overall, the security posture is adequate for an enterprise healthcare website but could benefit from additional best practices and disclosures.
Strategic Recommendations
Priority Actions for Security Improvement
Implement and publish a comprehensive security policy including incident response contacts.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Biogen
Biogen ist ein weltweit führendes Biotechnologie-Unternehmen und entwickelt innovative Arzneimitteltherapien für komplexe und schwere Erkrankungen. Die Forschungspipeline umfasst Wirkstoffkandidaten in Neurologie, Neuropsychiatrie, Immunologie und seltenen Erkrankungen.
excellent
consistent
Technical Stack
moderate
excellent
good
good
Security Assessment
- HTTPS enforced
- HttpOnly cookies
- Cookie consent management
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges
Get this report delivered to your inbox
Receive a summary of the biogen.de security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete biogen.de security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
No email authentication configured
CRITICALDomain is vulnerable to email spoofing
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 88 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Transfer Lock Not Enabled
MEDIUMDomain can be transferred without authorization
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
- •No domain protection locks enabled
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does biogen.de compare?
See how biogen.de stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the biogen.de report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the biogen.de report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about biogen.de
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published